Judge Cites 'Patent Misuse' In Ending Bard's $52M Lawsuit
An Arizona federal judge has decided that a license agreement Bard signed with a medical device company that sells vascular stents can't be enforced after the patent's expiration date, labeling Bard's...To view the full article, register now.
Already a subscriber? Click here to view full article